SHE:300463 - Maccura Biotechnology Co Ltd

Maccura Biotechnology Co Ltd
Sector: Health Care, Industry: Life Sciences Tools & Services

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	890.84M -16.7%	1.05B 17.7%	971.37M -7.4%	924.73M -4.8%	857.09M -7.3%	936.48M 9.3%	890.12M -5.0%	676.4M -24.0%	704.32M 4.1%	734.36M 4.3%	780.69M 6.3%	616.37M -21.0%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	396.65M -6.6%	432.51M 9.0%	419.99M -2.9%	421.71M 0.4%	391.82M -7.1%	469.8M 19.9%	368.45M -21.6%	302.17M -18.0%	341.53M 13.0%	309.5M -9.4%	342.12M 10.5%	262.5M -23.3%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	494.18M -23.4%	616.4M 24.7%	551.38M -10.5%	503.01M -8.8%	465.27M -7.5%	466.68M 0.3%	521.67M 11.8%	374.23M -28.3%	362.79M -3.1%	424.86M 17.1%	438.57M 3.2%	353.87M -19.3%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	590.24M -8.8%	697.82M 18.2%	742.37M 6.4%	644.54M -13.2%	626.19M -2.8%	717.62M 14.6%	725.13M 1.0%	519.71M -28.3%	609.76M 17.3%	581.23M -4.7%	733.55M 26.2%	470.02M -35.9%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	193.58M -13.0%	265.31M 37.1%	322.39M 21.5%	222.83M -30.9%	234.38M 5.2%	247.82M 5.7%	356.68M 43.9%	217.54M -39.0%	268.23M 23.3%	271.73M 1.3%	391.44M 44.1%	207.52M -47.0%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	300.6M -28.8%	351.08M 16.8%	228.99M -34.8%	280.18M 22.4%	230.89M -17.6%	218.86M -5.2%	164.99M -24.6%	156.69M -5.0%	94.57M -39.6%	153.13M 61.9%	47.14M -69.2%	146.35M 210.5%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	557.07M -	-	-	-	409.98M -	-	-	-	171.73M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	218.35M -30.3%	264.48M 21.1%	160.45M -39.3%	201.84M 25.8%	203.93M 1.0%	194.87M -4.4%	107.55M -44.8%	116.87M 8.7%	57.96M -50.4%	93.84M 61.9%	43.94M -53.2%	120.44M 174.1%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.392 -30.5%	0.476 21.5%	0.298 -37.4%	0.34 14.0%	0.333 -2.1%	0.318 -4.5%	0.182 -42.8%	0.19 4.5%	0.096 -49.7%	0.153 60.4%	0.075 -51.1%	0.2 167.0%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.392 -30.3%	0.475 21.1%	0.288 -39.2%	0.34 17.8%	0.333 -2.1%	0.318 -4.5%	0.174 -45.1%	0.19 8.9%	0.096 -49.7%	0.153 60.4%	0.072 -53.2%	0.2 178.9%